Nitrendipine
- Generic Name
- Nitrendipine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H20N2O6
- CAS Number
- 39562-70-4
- Unique Ingredient Identifier
- 9B627AW319
- Background
Nitrendipine is a calcium channel blocker with marked vasodilator action. It is an effective antihypertensive agent and differs from other calcium channel blockers in that it does not reduce glomerular filtration rate and is mildly natriuretic, rather than sodium retentive.
- Indication
For the treatment of mild to moderate hypertension
- Associated Conditions
- Hypertension
- Associated Therapies
- -
The Effect of Nitrendipine/Atenolol Combination on Blood Pressure Variability.
Phase 4
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-06-18
- Last Posted Date
- 2023-04-14
- Lead Sponsor
- Shanghai Jiao Tong University School of Medicine
- Target Recruit Count
- 32
- Registration Number
- NCT04931108
- Locations
- 🇨🇳
Shanghai Institite of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai, China
Treatment of Hypertension in Tibetan Adult Population
Phase 4
- Conditions
- Interventions
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2014-08-29
- Lead Sponsor
- West China Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT02217852
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
Sympathetic Nerve Activity in Renal Failure
Phase 4
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2009-05-05
- Last Posted Date
- 2015-03-17
- Lead Sponsor
- University of Erlangen-Nürnberg Medical School
- Registration Number
- NCT00892892
- Locations
- 🇩🇪
University of Erlangen-Nuremberg, CRC, med. Clinic 4, Erlangen, Bavaria, Germany
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath